Cargando…
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
BACKGROUND: In randomised clinical trials, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium–glucose cotransporter 2 (SGLT-2) inhibitors reduced cardiovascular events in patients with type 2 diabetes (T2D) at high cardiovascular risk, as compared to standard care. However, data compar...
Autores principales: | Thein, David, Christiansen, Mia Nielsen, Mogensen, Ulrik Madvig, Bundgaard, Johan Skov, Rørth, Rasmus, Madelaire, Christian, Fosbøl, Emil Loldrup, Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar, Køber, Lars, Kristensen, Søren Lund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339487/ https://www.ncbi.nlm.nih.gov/pubmed/32631337 http://dx.doi.org/10.1186/s12933-020-01078-5 |
Ejemplares similares
-
Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study
por: Zareini, B., et al.
Publicado: (2019) -
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine
por: Clausen, Marianne F., et al.
Publicado: (2021) -
Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study
por: Rørth, Rasmus, et al.
Publicado: (2018) -
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study
por: Ali, Sam Aiyad, et al.
Publicado: (2022) -
Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers
por: Madelaire, Christian, et al.
Publicado: (2020)